Sonoma Pharmaceuticals, Inc. (SNOA)
1.32
-0.01
(-0.75%)
USD |
NASDAQ |
Sep 09, 16:00
1.32
0.00 (0.00%)
After-Hours: 17:28
Sonoma Pharmaceuticals Total Assets (Quarterly) : 18.11M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 18.11M |
| March 31, 2026 | 14.07M |
| December 31, 2025 | 13.62M |
| September 30, 2025 | 13.86M |
| June 30, 2025 | 14.59M |
| March 31, 2025 | 13.80M |
| December 31, 2024 | 13.67M |
| September 30, 2024 | 13.68M |
| June 30, 2024 | 13.67M |
| March 31, 2024 | 14.89M |
| December 31, 2023 | 14.62M |
| September 30, 2023 | 13.64M |
| June 30, 2023 | 15.89M |
| March 31, 2023 | 16.41M |
| December 31, 2022 | 13.93M |
| September 30, 2022 | 14.96M |
| June 30, 2022 | 17.16M |
| March 31, 2022 | 19.18M |
| December 31, 2021 | 19.35M |
| September 30, 2021 | 19.83M |
| June 30, 2021 | 14.12M |
| March 31, 2021 | 14.99M |
| December 31, 2020 | 18.23M |
| September 30, 2020 | 18.14M |
| June 30, 2020 | 18.08M |
| Date | Value |
|---|---|
| March 31, 2020 | 14.56M |
| December 31, 2019 | 16.50M |
| September 30, 2019 | 16.14M |
| June 30, 2019 | 16.92M |
| March 31, 2019 | 14.45M |
| December 31, 2018 | 17.04M |
| September 30, 2018 | 14.35M |
| June 30, 2018 | 16.63M |
| March 31, 2018 | 19.21M |
| December 31, 2017 | 18.36M |
| September 30, 2017 | 20.15M |
| June 30, 2017 | 22.42M |
| March 31, 2017 | 25.46M |
| December 31, 2016 | 27.51M |
| September 30, 2016 | 9.241M |
| June 30, 2016 | 11.32M |
| March 31, 2016 | 13.80M |
| December 31, 2015 | 12.10M |
| September 30, 2015 | 13.58M |
| June 30, 2015 | 14.21M |
| March 31, 2015 | 15.05M |
| December 31, 2014 | 11.83M |
| September 30, 2014 | 18.39M |
| June 30, 2014 | 19.88M |
| March 31, 2014 | 20.79M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
| Johnson & Johnson | 201.06B |
| Eli Lilly & Co. | 142.28B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 11.51M |
| Shareholders Equity (Quarterly) | 6.594M |
| Debt to Equity Ratio | 0.1121 |
| Current Ratio | 2.987 |
| Net Debt Paydown Yield | -1.47% |